Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [31] Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: A post hoc analysis
    Jain R.
    Babcock T.
    Burtea T.
    Dirks B.
    Adeyi B.
    Scheckner B.
    Lasser R.
    Child and Adolescent Psychiatry and Mental Health, 5 (1)
  • [32] Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults
    Anthony L. Rostain
    Current Psychiatry Reports, 2009, 11 : 341 - 342
  • [33] Lisdexamfetamine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Rostain, Anthony L.
    CURRENT PSYCHIATRY REPORTS, 2009, 11 (05) : 341 - 342
  • [34] Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
    Popovic, Biljana
    Brattacharya, Pratik
    Sivaswamy, Lalitha
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (22) : 2005 - 2012
  • [35] Cost-utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom
    Zimovetz, E. A.
    Bischof, M.
    Joseph, A.
    Mauskopf, J. A.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [36] A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
    Wigal S.B.
    Kollins S.H.
    Childress A.C.
    Squires L.
    Brams M.
    Childress A.
    Lerner M.A.
    Moon E.
    Turnbow J.M.
    Vince B.
    Child and Adolescent Psychiatry and Mental Health, 3 (1)
  • [37] European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Higgins, Nicholas
    Lyne, Andrew
    Squires, Liza
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1208 - 1218
  • [38] Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: Sex and age effects and effect size across the day
    Wigal S.B.
    Kollins S.H.
    Childress A.C.
    Adeyi B.
    Child and Adolescent Psychiatry and Mental Health, 4 (1)
  • [39] Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (01) : 52 - 62
  • [40] Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Lecendreux, Michel
    Zuddas, Alessandro
    Banaschewski, Tobias
    Soutullo, Cesar
    Bloomfield, Ralph
    Hodgkins, Paul
    Gasior, Maria
    Coghill, David
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S223 - S223
12345